25 April 2022>: Clinical Research
A Retrospective Study of 320 Patients Treated with Carotid Artery Stenting at 4 General Hospitals in Zhejiang Province to Establish a Risk Score for Cerebral Hypoperfusion Syndrome
Yuan Liu 1B , Changyang Zhong 1ABCEF* , Peng Wang 2BC , Jianhong Yang 3DF , Chenghua Xu 4BF , Zuyong Zhang 5AFG*DOI: 10.12659/MSM.935697
Med Sci Monit 2022; 28:e935697
Table 1 Incidence and clinical outcomes of CHS after carotid stenting.
Number of cases | CHS occurrence number of cases (rate) | Clinical outcome (number of cases and percentage [%]) | |||||
---|---|---|---|---|---|---|---|
Death | Disability | Recovery | Become better | Automatic discharge | |||
Total number of cases | 320 | 68 (21.25%) | 6 (8.82) | 26 (38.24) | 10 (14.71) | 19 (27.94) | 7 (10.29) |
Test set | 225 | 47 (20.89%) | 4 (8.51) | 18 (38.30) | 7 (14.89) | 13 (27.66) | 5 (10.64) |
Validation set | 95 | 21 (22.11%) | 2 (9.52) | 8 (38.10) | 3 (14.29) | 6 (28.57) | 2 (9.52) |
CHS – cerebral hypoperfusion syndrome. |